2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎
反馈给我们。基本信息 | 登录收藏 | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | Human Vaccines & Immunotherapeutics HUM VACC IMMUNOTHER (此期刊被最新的JCR期刊SCIE收录) LetPub评分 6.3
50人评分
我要评分
声誉 7.5 影响力 5.1 速度 7.0 | |||||||||||||||||||||||||||||||
期刊ISSN | 2164-5515 | 微信扫码收藏此期刊 | ||||||||||||||||||||||||||||||
E-ISSN | 2164-554X | |||||||||||||||||||||||||||||||
2023-2024最新影响因子 (数据来源于搜索引擎) | 4.1 点击查看影响因子趋势图 | |||||||||||||||||||||||||||||||
实时影响因子 | 截止2024年10月29日:2.528 | |||||||||||||||||||||||||||||||
2023-2024自引率 | 9.80%点击查看自引率趋势图 | |||||||||||||||||||||||||||||||
五年影响因子 | 4.2 | |||||||||||||||||||||||||||||||
JCI期刊引文指标 | 0.85 | |||||||||||||||||||||||||||||||
h-index | 43 | |||||||||||||||||||||||||||||||
CiteScore ( 2024年最新版) |
| |||||||||||||||||||||||||||||||
期刊简介 |
| |||||||||||||||||||||||||||||||
期刊官方网站 | http://www.tandfonline.com/loi/khvi20 | |||||||||||||||||||||||||||||||
期刊投稿网址 | https://www.editorialmanager.com/HV | |||||||||||||||||||||||||||||||
期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Human Vaccines & Immunotherapeutics的语言要求,还能让Human Vaccines & Immunotherapeutics编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Human Vaccines & Immunotherapeutics编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||||||||||||
是否OA开放访问 | No LetPub与Taylor & Francis签署APC支持服务战略合作协议,选择APC支持服务可享受:多样化支付选项,国税发票,加速发表,京东购物卡福利。了解详情>>> | |||||||||||||||||||||||||||||||
通讯方式 | 530 WALNUT STREET, STE 850, PHILADELPHIA, USA, PA, 19106 | |||||||||||||||||||||||||||||||
出版商 | Landes Bioscience | |||||||||||||||||||||||||||||||
涉及的研究方向 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY-IMMUNOLOGY | |||||||||||||||||||||||||||||||
出版国家或地区 | UNITED STATES | |||||||||||||||||||||||||||||||
出版语言 | English | |||||||||||||||||||||||||||||||
出版周期 | ||||||||||||||||||||||||||||||||
出版年份 | 0 | |||||||||||||||||||||||||||||||
年文章数 | 452点击查看年文章数趋势图 | |||||||||||||||||||||||||||||||
Gold OA文章占比 | 80.48% | |||||||||||||||||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 80.75% | |||||||||||||||||||||||||||||||
WOS期刊SCI分区 ( 2023-2024年最新版) | WOS分区等级:2区
| |||||||||||||||||||||||||||||||
中国科学院《国际期刊预警 名单(试行)》名单 | 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||||||||||||
中国科学院SCI期刊分区 ( 2023年12月最新升级版) | 点击查看中国科学院SCI期刊分区趋势图
| |||||||||||||||||||||||||||||||
中国科学院SCI期刊分区 ( 2022年12月升级版) |
| |||||||||||||||||||||||||||||||
中国科学院SCI期刊分区 ( 2021年12月旧的升级版) |
| |||||||||||||||||||||||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2164-5515%5BISSN%5D | |||||||||||||||||||||||||||||||
平均审稿速度 | 网友分享经验: 一般,3-6周 | |||||||||||||||||||||||||||||||
平均录用比例 | 网友分享经验: 容易 | |||||||||||||||||||||||||||||||
LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在Human Vaccines & Immunotherapeutics顺利发表。
快看看作者怎么说吧:服务好评 论文致谢 | |||||||||||||||||||||||||||||||
期刊常用信息链接 |
|
|
|
中国学者近期发表的论文 | |
1. | A systematic review and meta-analysis of the seroconversion rates and adverse effects of COVID-19 mRNA vaccine and COVID-19 viral vector vaccine in kidney transplant recipient patients Author: Chen, Sikai; Wei, Wenxin; Huang, Fengyu; Wang, Jing; Li, Xingyu; Gen, Zhixin; Gao, Feng; Dong, Taiwei; Wei, Peifeng; Yang, Xinbo; Miao, Feng Journal: HUMAN VACCINES & IMMUNOTHERAPEUTICS. 2023; Vol. , Issue , pp. -. DOI: 10.1080/21645515.2023.2196893 PubMed DOI |
2. | Immunogenicity and safety of a live attenuated varicella vaccine co-administered with inactive hepatitis A vaccine: A phase 4, single-center, randomized, controlled trial Author: Sun, Dapeng; Yu, Dan; Du, Zhenhua; Jia, Ningning; Liu, Xiaodong; Sun, Jianwen; Xu, Qing; Sun, Zhuoqun; Luan, Chunfang; Lv, Jingjing; Xiong, Ping; Zhang, Li; Sha, Xueyan; Gao, Yongjun; Kang, Dianmin Journal: HUMAN VACCINES & IMMUNOTHERAPEUTICS. 2023; Vol. 19, Issue 1, pp. -. DOI: 10.1080/21645515.2022.2161789 PubMed DOI |
3. | Effectiveness of COVID-19 vaccines against SARS-CoV-2 Omicron variants during two outbreaks from March to May 2022 in Quzhou, China Author: Yin, Zhiying; Fang, Quanjun; Wen, Tingcui; Zheng, Canjie; Fu, Canya; Wang, Shuangqing; Li, Junji; Gong, Xiaoying Journal: HUMAN VACCINES & IMMUNOTHERAPEUTICS. 2023; Vol. , Issue , pp. -. DOI: 10.1080/21645515.2022.2163813 PubMed DOI |
4. | Establishment of the 1st Chinese national standard for CA6 neutralizing antibody Author: Wang, Yiping; Gao, Fan; Liang, Zhenglun; Sun, Huimin; Wang, Junzhi; Mao, Qunying Journal: HUMAN VACCINES & IMMUNOTHERAPEUTICS. 2023; Vol. 19, Issue 1, pp. -. DOI: 10.1080/21645515.2022.2164140 PubMed DOI |
5. | Willingness of college students to receive COVID-19 heterologous vaccination in Taizhou, China Author: Shao, Hui; Lin, Xiao-Qing; Chen, Yan; Lv, Li; Ying, Chen-Qian; Tung, Tao-Hsin; Zhu, Jian-Sheng Journal: HUMAN VACCINES & IMMUNOTHERAPEUTICS. 2023; Vol. 19, Issue 1, pp. -. DOI: 10.1080/21645515.2022.2158012 PubMed DOI |
6. | Gap between cognitions and behaviors among children's guardians of influenza vaccination: The role of social influence and vaccine-related knowledge Author: Wu, Jing; Wei, Zheng; Yang, Yingying; Sun, Xiu; Zhan, Siyi; Jiang, Qijing; Fu, Chuanxi Journal: HUMAN VACCINES & IMMUNOTHERAPEUTICS. 2023; Vol. 19, Issue 1, pp. -. DOI: 10.1080/21645515.2023.2166285 PubMed DOI |
7. | Mumps-specific antibody persistence in children aged 3-7 years immunized with two doses of mumps-containing vaccines: A prospective cohort study in Jiangsu Province, China Author: Sun, Jinfang; Li, Mingma; Zhang, Lei; Deng, Xiuying; Hu, Ying; Chen, Qiang; Wang, Zhiguo; Sun, Xiang; Liu, Yuanbao Journal: HUMAN VACCINES & IMMUNOTHERAPEUTICS. 2023; Vol. 19, Issue 1, pp. -. DOI: 10.1080/21645515.2023.2166758 PubMed DOI |
8. | COVID-19 vaccine uptake, reasons, and associated factors among older adults in Shenzhen, China Author: Xie, Pei; Shi, XiuYuan; Zhu, Bin; Zhao, Wenjing; Li, Xiaoheng; Zou, Xuan; Liu, Gang; Han, Xinxin Journal: HUMAN VACCINES & IMMUNOTHERAPEUTICS. 2023; Vol. , Issue , pp. -. DOI: 10.1080/21645515.2023.2196914 PubMed DOI |
9. | Preferences of general practitioners for delivering adult vaccination: A discrete choice experiment Author: Lv, Min; Shen, Yang; Li, Wentao; Wu, Jiang; Wen, Xiaojing; Zhu, Dawei; He, Ping Journal: HUMAN VACCINES & IMMUNOTHERAPEUTICS. 2023; Vol. 19, Issue 1, pp. -. DOI: 10.1080/21645515.2023.2167439 PubMed DOI |
10. | The complicated use of dupilumab in the treatment of atypical generalized pemphigus Erythematous: A report of two cases Author: Chen, Jie; Chen, Siji; Wu, Xia; Jiang, Xiaoyun; Wang, Yongdong; Cheng, Hao Journal: HUMAN VACCINES & IMMUNOTHERAPEUTICS. 2023; Vol. 19, Issue 1, pp. -. DOI: 10.1080/21645515.2022.2151290 PubMed DOI |
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2024 中国: LetPub上海 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室